Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation

In December 2019, a new severe acute respiratory syndrome coronavirus (SARS-CoV-2) causing coronavirus diseases 2019 (COVID-19) emerged in Wuhan, China. African countries see slower dynamic of COVID-19 cases and deaths. One of the assumptions that may explain this later emergence in Africa, and more...

詳細記述

保存先:
書誌詳細
出版年:Travel Med Infect Dis
主要な著者: Gendrot, Mathieu, Andreani, Julien, Boxberger, Manon, Jardot, Priscilla, Fonta, Isabelle, Le Bideau, Marion, Duflot, Isabelle, Mosnier, Joel, Rolland, Clara, Bogreau, Hervé, Hutter, Sébastien, La Scola, Bernard, Pradines, Bruno
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier Ltd. 2020
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7477610/
https://ncbi.nlm.nih.gov/pubmed/32916297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tmaid.2020.101873
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料